1. Home
  2. MIST vs ITRG Comparison

MIST vs ITRG Comparison

Compare MIST & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ITRG
  • Stock Information
  • Founded
  • MIST 2003
  • ITRG 1997
  • Country
  • MIST Canada
  • ITRG Canada
  • Employees
  • MIST N/A
  • ITRG N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ITRG Precious Metals
  • Sector
  • MIST Health Care
  • ITRG Basic Materials
  • Exchange
  • MIST Nasdaq
  • ITRG Nasdaq
  • Market Cap
  • MIST 145.3M
  • ITRG 452.9M
  • IPO Year
  • MIST N/A
  • ITRG N/A
  • Fundamental
  • Price
  • MIST $1.94
  • ITRG $2.66
  • Analyst Decision
  • MIST Strong Buy
  • ITRG Strong Buy
  • Analyst Count
  • MIST 3
  • ITRG 2
  • Target Price
  • MIST $6.33
  • ITRG $3.25
  • AVG Volume (30 Days)
  • MIST 1.2M
  • ITRG 2.2M
  • Earning Date
  • MIST 11-11-2025
  • ITRG 11-12-2025
  • Dividend Yield
  • MIST N/A
  • ITRG N/A
  • EPS Growth
  • MIST N/A
  • ITRG N/A
  • EPS
  • MIST N/A
  • ITRG 0.09
  • Revenue
  • MIST N/A
  • ITRG $148,447,000.00
  • Revenue This Year
  • MIST N/A
  • ITRG $871.24
  • Revenue Next Year
  • MIST N/A
  • ITRG N/A
  • P/E Ratio
  • MIST N/A
  • ITRG $30.64
  • Revenue Growth
  • MIST N/A
  • ITRG N/A
  • 52 Week Low
  • MIST $0.63
  • ITRG $0.79
  • 52 Week High
  • MIST $2.75
  • ITRG $2.86
  • Technical
  • Relative Strength Index (RSI)
  • MIST 64.09
  • ITRG 69.00
  • Support Level
  • MIST $1.75
  • ITRG $2.54
  • Resistance Level
  • MIST $2.06
  • ITRG $2.86
  • Average True Range (ATR)
  • MIST 0.09
  • ITRG 0.14
  • MACD
  • MIST 0.02
  • ITRG 0.00
  • Stochastic Oscillator
  • MIST 66.67
  • ITRG 73.58

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: